TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMNM

Immunome Inc

Healthcare · Biotechnology

25.10$ +4.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Immunome Inc (IMNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 565 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMNM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
93 149 320 296 257 240 343 296 299 683 620 565
91 145 313 284 244 221 323 277 280 661 594 538
91 99 270 165 156 143 258 144 273 653 583 218
91 138 310 278 240 217 317 268 273 653 583 520
0.0 0.3
87 29 34 42 42 59 36 27 35 49 31 40
23 22 31 40 40 54 31 23 31 45 27 36
0.2 0.3 0.4 0.3 0.3 0.1
2.8 3.3 7.2 7.0 3.5 14 9.1 4.7 6.1 3.3 5.5 6.0
6.1 120 286 254 215 181 307 269 264 634 589 525
-130 -223 -352 -388 -436 -516 -557 -601 -658 -728 -782 -855
12 22 10 60 60 63 79 87 88 87 113 113

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?